Drug profile · INN
methylphenidate
COTEMPLA XR-ODT
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
methylphenidate (COTEMPLA XR-ODT) is an FDA-listed pharmaceutical active ingredient. Route of administration: transdermal. Current US regulatory status: approved.
Key facts
INN methylphenidate
Brand COTEMPLA XR-ODT
Route TRANSDERMAL
Formulation TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE
Related patents
Search patents →Frequently asked questions
What is methylphenidate?
methylphenidate (COTEMPLA XR-ODT) is an FDA-listed pharmaceutical active ingredient. Route of administration: transdermal. Current US regulatory status: approved.
What is the brand name for methylphenidate?
COTEMPLA XR-ODT is a marketed brand name for methylphenidate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of methylphenidate?
methylphenidate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.